Glenmark launches drug in India to treat Type 2 diabetes
Glenmark Pharmaceuticals has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium Glucose Co-Transporter Inhibitor (SGLT2i) – Remogliflozin Etabonate and another widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) –…
India to play vital role in equitable distribution of COVID-19 vaccines around the world: Pharma industry
New Delhi: With vaccine rollout beginning in some countries, the world ravaged by the COVID-19 pandemic is looking to India for the large-scale production and supply of coronavirus vaccines as…
WHO Launches Covid-19 App To Counter Pandemic Misinformation
New Delhi : The World Health Organization (WHO) has launched a mobile application to provide users with the latest updates on the coronavirus disease (Covid-19). Called the WHO Covid-19 app,…
AstraZeneca-Oxford Covid Vaccine Has ‘Winning Formula’ : Chief Executive
London : The Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a “winning formula” for efficacy, the company’s chief executive said on…
Govt Job for Ph.D, M.Pharm, M.Sc at Indian Pharmacopoeia Commission
The Indian Pharmacopoeia Commission (IPC) has been established as an autonomous Institution under the Ministry of Health & Family Welfare, Govt. of India primarily with the objectives of regularly updating…
Lupin gets tentative nod from USFDA for its toenail fungus treatment topical solution
NEW DELHI: Drug firm Lupin on Thursday said it has received tentative nod from the US health regulator to market generic Efinaconazole topical solution used for treatment of fungal infections of toenails. The company has received…
Zydus Cadila seeks approval to begin phase III trials of COVID-19 vaccine ZyCoV-D
Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, novel biologicals, biosimilars and vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was…
AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin
The All India Institute of Medical Sciences (AIIMS) based in New Delhi on Thursday invited volunteers for the Phase III clinical trial of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ for which…
Aurobindo Pharma signs pact with Covaxx for Covid-19 vaccine
Hyderabad: Aurobindo Pharma Ltd and Covaxx, a US-based company, have entered into an exclusive license agreement to develop, commercialise and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and UNICEF. According…
Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commercialising its nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Glenmark Specialty, a Switzerland-based unit…
